Deep-tech Startup Funding: What Types of Funding and Investors Should You Seek in 2026?

A deep tech startup is not funded in the same way as a traditional digital company. Based on a scientific or technological breakthrough, it generally must overcome significant technical hurdles before bringing its product to market.

Hiring scientific staff, conducting trials, purchasing equipment, managing intellectual property, developing prototypes, and scaling up production thus generate significant expenses long before the first revenues are generated.

Funding for a deep-tech startup generally relies on four main categories of solutions:

• Government assistance, such as grants, subsidies, and repayable advances;
• Tax and social security measures, including the Research Tax Credit and the Young Innovative Enterprise (JEI) status;
• Private equity, provided by business angels and venture capital funds;
• Debt and hybrid instruments, such as innovation loans and convertible bonds.

The goal is not to accumulate funding mechanisms. Rather, it is to build a coherent continuum that aligns with the level of technological maturity, the next steps in R&D, and available cash flow. Funding must therefore be viewed as a journey from scientific maturation to industrialization.

Deep-tech Startup Funding: Why Are the Needs So Specific?

R&D expenses incurred before the first revenue was generated

A deep-tech company must demonstrate the validity of its technology before it can confirm its commercial potential. As a result, it incurs research and development expenses very early on:

• Recruitment of researchers, PhDs, technicians, and engineers;
• Purchase or rental of scientific equipment;
• Conducting tests and feasibility studies;
• Outsourcing to specialized laboratories;
• Filing, extending, and defending patents;
• Design of proof-of-concepts and prototypes.

These expenses are incurred even though the product, process, or business model has yet to be validated. The financing plan must therefore cover a longer period than that of a startup offering a digital service that can be brought to market quickly.

Technological barriers that increase the risk

The risk associated with a deep tech startup is not solely commercial. The technology itself may fail to perform as expected, face reproducibility issues, or prove too complex to scale up for mass production.

A proof of concept helps gradually reduce this uncertainty. To convince an investor, the startup must present measurable technological milestones:

• Scientific performance targets;
• Test drives;
• Hypotheses to be confirmed;
• Expected deliverables;
• Criteria for success or failure;
• Targeted progress on the TRL scale.

The TRL scale helps illustrate the progression from an observed scientific principle to an operational system under real-world conditions.

A Complex Transition from the Lab to the Market

Between scientific discovery and commercialization lies a critical maturation phase. The technology must move out of the laboratory, be integrated into a prototype, tested in a representative environment, and then transformed into a demonstrator ready for industrial production.

This period, sometimes referred to as the “valley of death,” involves several risks: technical uncertainty, rising costs, a lack of revenue, and difficulty in convincing private investors. Public funding therefore plays a crucial role in mitigating risk prior to a larger round of fundraising.

‍

Deep Tech Startup Funding: Mapping Available Solutions

Non-dilutive financing

Non-dilutive financing allows companies to fund their growth without immediately giving up a portion of their equity. These include, in particular:

• Grants;
• Innovation contests;
• Recoverable advances;
• The Research Tax Credit;
• Regional aid;
• Honor loans;
• Tax exemptions associated with JEI status.

Their main advantage is that they preserve the founders' ownership stakes. However, they impose specific eligibility criteria, submission deadlines, and require a detailed justification of expenses.

Dilutive Financing

Business angels, seed funds, venture capital funds, and industrial investors provide capital in exchange for an equity stake in the company.

This dilution may be necessary when a startup needs to finance several years of development, recruit quickly, or prepare for a costly scaling-up effort. The investor may also contribute industry expertise, an industrial network, and the ability to participate in subsequent funding rounds.

Debt and Hybrid Instruments

Innovation loans, guarantees, repayable advances, and convertible bonds fall somewhere between public financing and equity investment.

Debt helps preserve shareholder equity, but it must be repaid. Convertible bonds delay dilution without necessarily preventing it, since they can be converted into shares during a subsequent capital raise.

What solutions are available depending on the stage of maturity?

TRL 1–3: Funding Maturation and Feasibility

At this stage, the project aims to validate its scientific principles, feasibility, and potential for commercialization.

Appropriate financing options may include:

• A laboratory’s premature delivery programs;
• Funding for a SATT;
• The i-PhD Competition;
• The French Tech Emergence Scholarship;
• Regional aid;
• Academic incubators;
• Personal contributions and "love money."

The French Tech Emergence Grant can provide up to 90,000 euros to fund the development and technical and economic validation of a startup. Expenses incurred prior to submitting the application are not eligible.

‍

‍

TRL 3–5: Funding for Proof of Concept and Prototyping

The startup then turns its scientific findings into a proof of concept and then into a prototype. The requirements relate to the R&D team, testing, subcontracting, equipment, and intellectual property.

Several strategies can be combined:

• i-Lab Contest;
• Deeptech Development Assistance;
• Research Tax Credit;
• JEI Status;
• Business angels;
• Specialized seed funds.

The i-Lab competition can support the final development of an innovative product, process, or service with a grant of up to 600,000 euros. It also serves as a sign of credibility to investors.

TRL 5–7: Funding the Demonstrator

At this stage, the technology must operate in a representative environment. The company funds demonstrators, pilot projects, testing campaigns, regulatory validations, and preparations for industrialization.

In particular, it can mobilize:

• Deeptech Development Assistance;
• The i-Nov Contest;
• The CIR;
• Industrial partnerships;
• A fundraising round with deep-tech funds;
• Certain forms of European funding.

Deeptech Development Assistance can total up to 2 million euros. It combines a grant and a recoverable advance to fund an industrial research or experimental development program.

TRL 7–9: Funding Industrialization

Once the technology has been proven, the focus shifts to production equipment, certifications, working capital requirements, and the commercial launch.

Possible solutions include:

• France 2030 calls for proposals;
• Subsidies for the first plant;
• The EIC Accelerator;
• The Innovation Debt;
• Industrial investors;
• Series A or B funding rounds.

In 2026, the EIC Accelerator anticipates a grant of less than 2.5 million euros and an investment ranging from 500,000 to 10 million euros.

The Main Government Grants for a Deep Tech Startup

The French Tech Emergence Scholarship

The French Tech Emergence Grant Program provides early-stage funding to support feasibility studies and technical and economic validation.

In particular, it may cover:

• Technical studies;
• Design work;
• Laboratory services;
• Intellectual property expenses;
• Market analyses related to the project's feasibility.

The application must be submitted before the company incurs the expenses it wishes to have funded.

Deeptech Development Assistance

The Deeptech Development Grant is intended for more structured industrial research and experimental development programs .

It can fund:

• Salaries for the scientific team;
• Equipment and Depreciation;
• Patents;
• Technical services;
• The tests;
• Outsourcing R&D.

Sales, marketing, and communications expenses must be clearly distinguished from the research program.

The i-PhD, i-Lab, and i-Nov Competitions

These competitions correspond to different levels of maturity:

• I-phd supports PhD graduates and early-career researchers in transforming their scientific work into entrepreneurial projects;
• I-Lab supports the creation of technology companies and the development of innovations;
• I-Nov funds more advanced R&D projects led by startups and small and medium-sized enterprises.

Beyond funding, being selected can serve as a seal of approval with industrial partners, investors, and future employees.

‍

OC French Tech Seed

French Tech Seed helps scale up a private funding round through convertible bonds. The investment ranges from 50,000 to 250,000 euros and can reach up to 500,000 euros.

This mechanism has several distinctive features:

• No immediate dilution;
• Conversion may be possible in a later round;
• Repayment to be expected if there is no conversion;
• Funding is contingent upon private contributions.

Potential dilution and repayment terms must be included in the financing plan.

Deep Tech Startup Funding: Comparing Key Programs

The requirements, application deadlines, and funding amounts are subject to change. Therefore, each official document must be reviewed before developing the financing plan.

Using the CIR and JEI Status

The Research Tax Credit reduces the cost of certain R&D expenses:

• Salaries of researchers and technicians;
• Depreciation of equipment;
• Services entrusted to accredited organizations;
• Patent-related expenses;
• Eligible research projects.

In mainland France, the CIR accounts for 30% of research expenditures up to 100 million euros, and 5% for amounts above that. However, the startup must be able to pre-finance its expenditures.

The JEI status can also reduce certain social security contributions related to research staff. For companies established on or after January 1, 2023, this status requires, in particular, that the company be less than eight years old, meet the definition of an SME, and devote at least 20% of its expenses to R&D. It can be combined with the CIR.

This combination requires thorough documentation:

• Project-Based Cost Accounting;
• Timesheets;
• Invoices;
• Subcontracts;
• Scientific reports;
• Justification for grants received.

The same expense should not be funded twice.

Raising funds from private investors

Deep-tech investors don't always expect a product that's already on the market. However, they do look for evidence that risk has been mitigated:

• A convincing proof of concept;
• Secure intellectual property;
• A complementary scientific and sales team;
• Reproducible experimental results;
• A clearly defined market;
• A regulatory strategy;
• A path to industrialization;
• A credible estimate of future financial needs.

The choice of an investor should not be based solely on the proposed valuation. The investor’s industry expertise, network, investment horizon, and ability to participate in subsequent funding rounds are also key factors.

An investor presentation typically includes a pitch deck, a cash flow forecast, TRL milestones, an intellectual property strategy, a capital table, contracts with pharmaceutical companies, and a structured data room.

‍

Deep-tech Startup Funding: How to Combine Different Funding Sources?

A funding path might, for example, follow this sequence:

1. Pre-commercialization in a laboratory or through a technology transfer agency;
2. French Tech Emergence Grant;
3. i-PhD or i-Lab Competition;
4. Utilization of the JEI status and the CIR;
5. Deeptech Development Assistance;
6. Fundraising from business angels or a seed fund;
7. Presentation by French Tech Seed;
8. I-Nov or EIC Accelerator;
9. Funding for Industrialization.

This sequence is not a mandatory process. It depends on the sector, regulations, the level of technological maturity, and the capital intensity of the project.

Management must be carried out using milestones. For each phase, the company must specify:

• The TRL at the start and finish;
• Work to be done;
• The budget;
• Duration;
• Targeted assistance;
• The required equity capital;
• The filing and decision dates;
• Interim cash flow needs;
• The indicator used to validate the milestone.

Government grants extend cash flow and reduce risk, but they do not always replace a funding round. Some programs require the ability to co-finance. Conversely, accepting dilution at the right time can help accelerate hiring or secure scaling up.

Deep Tech Startup Funding: Mistakes to Avoid

Several mistakes can undermine a financing strategy:

• Incurring expenses before submitting an application for assistance;
• Underestimating payment deadlines;
• Prepare the budget without the need for interim cash flow;
• Present a scientific project with no identifiable commercial potential;
• Neglecting patent ownership and freedom to operate;
• Introducing more systems without verifying their compatibility;
• Seeking investors without a clear plan for the next rounds;
• Underestimating the resources needed for administrative follow-up.

Scientific quality must always be linked to an application, a market, a competitive advantage, and an industrial trajectory. Intellectual property issues must also be clarified at a very early stage: patent ownership, licensing agreements with the laboratory, joint ownership agreements, confidentiality, and dependence on third-party technology.

Increasing aid without an overall strategy can lead to duplicate spending, inconsistent timelines, an administrative burden, or a lack of funds at a critical moment.

Securing funding for a deep tech startup therefore requires aligning the scientific strategy, filing schedules, equity capital, and industrial roadmap.

At Dynergie, we help startups and innovative companies identify relevant funding programs, structure their financing plans, and put together their applications. Our support enables them to leverage the right resources at the right time, ensure that expenses are eligible, and present a coherent, well-documented, and credible project to funders.

‍